Bayer/Onyx’s Nexavar Falters In Lung-Cancer Phase III

Success eludes ESCAPE trial, stopped early by panel finding.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet